Regulatory Updates
🌏 NMPA Page 2NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 13–24 of 87 articles
Regulatory Round-Up: Key Drug Approvals on May 18, 2026
Optical Coherence Tomography Gains Regulatory Traction in Pharma Filings
Datroway Approved: A New Hope for Metastatic TNBC Patients
Kelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide
AbbVie Secures FDA Approval for ImmunoGen's Elahere
PREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI
PMDA Approves New Pharmaceuticals and Medical Devices: What's New
Global Regulatory Agencies Update Real-World Evidence Guidance for Decision-Making
China's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge
ASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements
Hong Kong Overhauls Drug Approval Process: What Pharma BD Teams Need to Know
CDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy